About Calyx Bio-Ventures
Calyx Bio-Ventures holds biotechnology assets. It owns REM technology platform, the rights to use the ACE System technology for gene therapy and transgenics, and a 29% interest in Agrisoma Biosciences, Inc.
Investment Details
Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Agriculture, Healthcare, IoT (+2 more)
Investor Type
Micro VC
Investment Focus
Focus Areas